Dr. Maha Mohamed

Associate Professor

Faculty Office Ext.

3052

Faculty Building

UB1

Office Number

362

Biography

Dr. Maha M Salah Eldin, received her bachelor degree of Medicine and Surgery (with honors), Faculty of Medicine, Cairo University, Egypt, in 2007. Then, she received the master's and doctoral degrees in Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Egypt in 2014 and 2017 respectively. She is currently assistant professor in the Biotechnology School, Nile University, Giza, Egypt. Since 2012, she has been teaching Medical Biochemistry and Molecular Biology Course which includes Macromolecules Chemistry and Metabolism, Vitamins Metabolism, Metabolic Integrations in the Human Body, Molecular Biology and Cancer Biology at Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Egypt. Dr. Maha M Salah Eldin served as an Organizing Committee member for the 4th (BioChemCairo 2018) and 5th (BioChemCairo 2020) annual conferences of Medical Biochemistry and Molecular Biology department, Faculty of Medicine, Cairo University, Cairo, Egypt. Since 2017, she has been a mentor for medical students enrolled in the Integrated Program of Kasr Alainy (IPKA), Faculty of Medicine, Cairo University, which aims at providing high-quality education with full academic supervision of the students and continuous evaluation of their performance. Her research interest is in cancer and possible ways for early diagnosis and effective treatment.

Recent Publications

Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopenia

The main aim of this study was to assess the expression level of circulating long non-coding RNA maternally expressed gene 3 (lncRNA-MEG3), microRNA (miR-125a-5P), the chemokine C-X-C motif ligand13 (CXCL13), and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) in immune thrombocytopenia (ITP) cases and to study its relation to the disease severity and treatment response
.

Long noncoding RNA (taurine upregulated gene 1) and micro RNA-377: emerging players in the development of metabolic syndrome among psoriasis patients

Background: Psoriasis (PsO) is an immune-mediated dermatosis and systemic inflammatory condition that can affect the skin, joints, and other organs and tissues with a range of comorbidities. The activation of proinflammatory cytokines is the primary cause of the development of skin lesions in PsO. Patients with PsO have a higher risk of developing cardiovascular metabolic comorbidities; among

Can Micro RNA-24 Affect the Cardiovascular Morbidity in Systemic Lupus Erythematosus by Targeting YKL-40?

Systemic lupus erythematosus (SLE) is an autoimmune disease with inflammatory nature. One of the leading causes of death in SLE patients is cardiovascular (CVS) morbidity. MiRNA-24 is highly expressed in vascular endothelial cells (VECs). This dysregulated expression pattern is associated with dysfunction or even damage of VECs and leads to the occurrence of cardiovascular diseases. YKL-40 is an
Healthcare
1

Prognostic significance of the genetic variant of lymphotoxin alpha (p.Thr60Asn) in egyptian patients with advanced hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide in terms of mortality, and susceptibility is attributed to genetic, lifestyle, and environmental factors. Lymphotoxin alpha (LTA) has a crucial role in communicating the lymphocytes with stromal cells and provoking cytotoxic effects on the cancer cells. There are no reports on the contribution of the LTA (c
Healthcare

Association between long noncoding RNA taurine-upregulated gene 1 and microRNA-377 in vitiligo

Background: Taurine-upregulated gene 1 (TUG1) is one of the long noncoding RNAs (lncRNAs) that plays a role in melanogenesis. MicroRNA-377 (miRNA-377) is a conserved noncoding RNA that regulates angiogenesis and promotes oxidative stress. Peroxisome proliferator-activated receptors (PPARs) are components of the nuclear hormone receptor superfamily. PPAR-γ activators stimulate melanogenesis

Artificial Intelligence
Healthcare
Software and Communications

Support for increased cardiovascular risk in non-segmental vitiligo among Egyptians: A hospital-based, case–control study

Background: Data have been accumulating in the past few years that identify vitiligo as a disorder with systemic implications. Results and methods: In this hospital-based, cross-sectional, case–control study, 50 patients with non-segmental vitiligo and 50 age- and sex-matched controls underwent analysis of serum lipid profile, oxidative stress biomarkers and carotid duplex. Hydrogen peroxide (H2O2

Artificial Intelligence
Healthcare
Innovation, Entrepreneurship and Competitiveness
Research Tracks
  • Cancer Biology.
  • Dermatology Disorders.
  • Autoimmune diseases.
  • Stem cells.
Projects
1

Online Pharmacogenomics and Personalized Medicine Diploma and Master’s Program

Project number: 617303-EPP-1-2020-1-EG-EPPKA2-CBHE-JP. Funding agency: The Education, Audiovisual and Culture Executive Agency (EACEA). Submitted to the call: Erasmus+ KA2 (Capacity Building in Higher Education). Description The OPPM project presents a two-year postgraduate academic program, which has already been granted accreditation in both Egypt and Lebanon. The first year focuses on a diploma